Success Story: NIW Approved Without RFE! We helped An Indian Assistant Professor Secure Success
Client’s Testimonial:
"I would like to thank the Chen Immigration team and the attorney I worked with for their help with the EB-2 NIW petition. The team is professional and provided assistance throughout the process.”
On April 2nd, 2026, we received another EB-2 NIW (National Interest Waiver) approval for an Assistant Professor in the Field of Pediatric Critical Care Medicine (Approval Notice).
General Field: Pediatric Critical Care Medicine
Position at the Time of Case Filing: Assistant Professor
Country of Origin: India
State of Residence at the Time of Filing: Texas
Approval Notice Date: April 2nd, 2026
Processing Time: 4 months, 19 days (Premium Processing Upgrade Requested)
Case Summary:
The client holds an MBBS that was evaluated as equivalent to an advanced U.S. medical degree, which positioned him for the advanced-degree NIW framework. It also framed his case around a proposed endeavor focused on basic science, translational, and clinical research in pediatrics and pediatric critical care, particularly the use of molecular, immunologic, and computational methods to connect biomarkers with patient outcomes so as to improve care for critically ill children.
A central strength of the case was how the petition tied the client’s work to substantial merit and national importance without relying on abstract claims. Rather than merely saying his research concerned children’s health, the filing emphasized that his work addressed serious pediatric critical illnesses and aimed to improve clinical outcomes, precision interventions, and evidence-based care. It also highlighted that his research had implications for biomarker development, neuroinflammation, infection-related issues, and critical care management, which helped show that the endeavor could affect both medical practice and broader U.S. health priorities. The petition further noted that the client’s research had received support from a major U.S. federal biomedical funding source, which was relevant not because funding alone proves eligibility, but because an adjudicator could view such support as independent evidence that the work aligns with recognized national interests.
On the publication side, the client’s record was presented as meaningful and credible: 12 peer-reviewed journal articles, including 8 first-authored articles; 8 abstracts, including 7 first-authored abstracts; and 8 book chapters, including 2 first-authored chapters. Likewise, the client’s 194 citations were not framed as self-proving. The petition explained why citation evidence matters, and it further strengthened the argument by showing that some of the client’s publications performed at notably high citation percentiles for their year and field. That type of comparative analysis is often more persuasive to adjudicators than raw counts alone because it helps distinguish influence from mere publication activity. The petition also relied on peer review as evidence of standing in the field. The client had completed at least 30 reviews to date.
Overall, this approval appears to have rested on a balanced NIW presentation: an advanced-degree professional in pediatric critical care medicine; a clearly defined research endeavor with substantial merit and national importance; a current academic medical role supporting continued work in the field; a publication and citation record showing real scholarly traction; substantial peer-review activity; and additional support indicating that the client’s research carried recognized value for U.S. interests.
In short, the petition did not treat metrics as enough on their own. It translated those metrics into a broader story about why the client’s ongoing research could materially benefit pediatric healthcare in the United States.